Cirtronics is sponsoring the Product Development track at this year’s MD+M | BIOMEDigital event on 6-7 April 2021. Engaging early with partners is vital in the product development process. 

At Cirtronics, early engagement includes progressing medical devices through its Transition to Manufacturing (T2M) facility and services. T2M accelerates the product’s move to manufacturing and shortens time to market. 

Jim McCall, director of manufacturing, said: “T2M optimises product build processes before moving into production, creating an efficient transfer to manufacturing and consistent results. 

“By leveraging early access to engineers and process equipment in our T2M facility, we’re able to optimise the build for production. Working with our supply chain experts, we review the bill of material and create a sourcing strategy that aligns with the specific needs of our customer. Our T2M services accelerate the transition of complex systems to full-scale production here in our FDA registered facility. T2M saves money by avoiding line stoppages and build adjustments once we’re in full production.”

These services strengthen complex system builds, including medical devices that incorporate lasers and optics that have exacting quality and regulatory requirements.